Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€22.40
Target price
20.11.24
€32.94
Performance (%)
187.95%
Price
03.10.24
€64.50
Summary
This prediction is currently active. With a performance of 187.95% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | 0.000% | 0.000% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $36.00 price target on the stock.
Ratings data for INSM provided by MarketBeat